C. DIFFICILE
CLOSTRIDIUM DIFFICILE, ALSO KNOWN AS C. DIFFICILE OR C. DIFF, IS A GRAM-NEGATIVE, ANAEROBIC, SPORE-FORMING BACTERIUM. CLOSTRIDIUM DIFFICILE IS A LEADING CAUSE OF INFECTIOUS DIARRHOEA IN HOSPITALS AND LONG-TERM CARE FACILITIES IN THE UNITED STATES AND EUROPE.
C. difficile spores are resistant to standard cleaning and disinfection procedures. As a result, C. difficile spores can persist on environmental surfaces for long periods of time.
Transmission of C. difficile typically occurs when patients are exposed to contaminated surfaces or instruments. The most common symptom of C. difficile infection is diarrhoea. Other associated symptoms include fever, abdominal pain, and nausea. C. difficile infection can be diagnosed using stool culture or polymerase chain reaction (PCR) testing. Treatment of C. difficile infection typically involves the use of antibiotics
Due to its increased sensitivity, Senzo’s Amplified Lateral Flow (ALF) will for the first time bring Lateral Flow price, speed and convenience to some of the world’s most deadly diseases, without sacrificing accuracy.
By moving the diagnosis of these targets from the laboratory to surgery, pharmacy and home we will increase the number of cases diagnosed, at an earlier stage of infection, thereby improving treatment outcomes and reducing mortality rates.
